Humana (NYSE:HUM) Shares Down 0.6%

Humana Inc. (NYSE:HUM) shares were down 0.6% during mid-day trading on Friday . The stock traded as low as $313.86 and last traded at $314.45. Approximately 187,994 shares traded hands during trading, a decline of 91% from the average daily volume of 2,014,160 shares. The stock had previously closed at $316.29.

Analysts Set New Price Targets

Several equities analysts recently issued reports on HUM shares. Bank of America restated a “neutral” rating and set a $342.00 price target (down from $470.00) on shares of Humana in a research report on Tuesday, April 2nd. Deutsche Bank Aktiengesellschaft lowered Humana from a “buy” rating to a “hold” rating and reduced their price target for the stock from $595.00 to $360.00 in a research report on Thursday, January 25th. TD Cowen cut their price objective on Humana from $427.00 to $396.00 and set a “buy” rating on the stock in a research report on Tuesday, April 2nd. Barclays cut their price objective on Humana from $356.00 to $310.00 and set an “equal weight” rating on the stock in a research report on Tuesday, April 2nd. Finally, StockNews.com lowered Humana from a “strong-buy” rating to a “hold” rating in a research report on Friday, January 26th. Eleven equities research analysts have rated the stock with a hold rating and nine have given a buy rating to the company. According to data from MarketBeat, the company has an average rating of “Hold” and a consensus target price of $465.42.

Humana Trading Down 1.2 %

The company has a market cap of $37.71 billion, a PE ratio of 15.77, a PEG ratio of 1.85 and a beta of 0.45. The company has a current ratio of 1.59, a quick ratio of 1.59 and a debt-to-equity ratio of 0.63. The stock has a 50 day moving average price of $347.21 and a 200 day moving average price of $429.35.

Humana (NYSE:HUM) last announced its quarterly earnings data on Thursday, January 25th. The insurance provider reported ($0.11) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.76 by ($0.87). The company had revenue of $26.46 billion for the quarter, compared to analysts’ expectations of $25.47 billion. Humana had a net margin of 2.34% and a return on equity of 19.44%. The firm’s quarterly revenue was up 17.9% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.62 EPS. Sell-side analysts predict that Humana Inc. will post 16.06 EPS for the current fiscal year.

Humana Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, April 26th. Shareholders of record on Friday, March 29th will be paid a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a yield of 1.13%. The ex-dividend date of this dividend is Wednesday, March 27th. Humana’s payout ratio is 17.86%.

Insider Buying and Selling at Humana

In related news, Director Jorge S. Mesquita acquired 545 shares of the stock in a transaction on Tuesday, February 20th. The stock was acquired at an average price of $367.09 per share, for a total transaction of $200,064.05. Following the completion of the purchase, the director now owns 2,578 shares of the company’s stock, valued at $946,358.02. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 0.32% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Several hedge funds have recently modified their holdings of HUM. Cibc World Market Inc. raised its stake in shares of Humana by 4.0% in the first quarter. Cibc World Market Inc. now owns 5,709 shares of the insurance provider’s stock worth $2,484,000 after purchasing an additional 217 shares during the last quarter. Blair William & Co. IL raised its stake in shares of Humana by 0.6% in the first quarter. Blair William & Co. IL now owns 5,660 shares of the insurance provider’s stock worth $2,463,000 after purchasing an additional 32 shares during the last quarter. Cetera Investment Advisers raised its stake in shares of Humana by 0.5% in the first quarter. Cetera Investment Advisers now owns 4,906 shares of the insurance provider’s stock worth $2,135,000 after purchasing an additional 26 shares during the last quarter. Sequoia Financial Advisors LLC raised its stake in shares of Humana by 19.0% in the first quarter. Sequoia Financial Advisors LLC now owns 615 shares of the insurance provider’s stock worth $268,000 after purchasing an additional 98 shares during the last quarter. Finally, Candriam Luxembourg S.C.A. raised its stake in shares of Humana by 25.0% in the first quarter. Candriam Luxembourg S.C.A. now owns 29,809 shares of the insurance provider’s stock worth $12,971,000 after purchasing an additional 5,964 shares during the last quarter. Hedge funds and other institutional investors own 92.38% of the company’s stock.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.